Benjamin Burnett
Stock Analyst at Stifel
(1.92)
# 2,863
Out of 4,829 analysts
71
Total ratings
38.78%
Success rate
-9.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Maintains: Hold | $5 → $3 | $1.07 | +180.37% | 3 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $53 → $49 | $37.59 | +30.35% | 6 | Feb 13, 2025 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $59.50 | +105.04% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $18.24 | +278.29% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $18.35 | +270.57% | 7 | Sep 10, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.17 | +293.16% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $6.47 | +788.72% | 4 | Apr 1, 2024 | |
| DTIL Precision BioSciences | Maintains: Buy | $690 → $780 | $5.22 | +14,842.53% | 2 | Sep 10, 2021 | |
| BLUE bluebird bio | Upgrades: Buy | $1,880 → $1,400 | $3.29 | +42,453.19% | 3 | Mar 27, 2020 | |
| RVMD Revolution Medicines | Maintains: Buy | $78 → $64 | $41.88 | +52.82% | 5 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $94 | $46.65 | +101.50% | 7 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4 | $1.36 | +194.12% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.37 | +629.93% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.93 | +1,195.34% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.71 | +3,257.58% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $0.75 | +2,042.47% | 1 | Jan 6, 2021 |
Fate Therapeutics
Mar 6, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $1.07
Upside: +180.37%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Hold
Price Target: $53 → $49
Current: $37.59
Upside: +30.35%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $59.50
Upside: +105.04%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $18.24
Upside: +278.29%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $18.35
Upside: +270.57%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.17
Upside: +293.16%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $6.47
Upside: +788.72%
Precision BioSciences
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $5.22
Upside: +14,842.53%
bluebird bio
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $3.29
Upside: +42,453.19%
Revolution Medicines
Apr 1, 2025
Maintains: Buy
Price Target: $78 → $64
Current: $41.88
Upside: +52.82%
Jan 24, 2025
Maintains: Buy
Price Target: $90 → $94
Current: $46.65
Upside: +101.50%
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.36
Upside: +194.12%
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $1.37
Upside: +629.93%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $1.93
Upside: +1,195.34%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.71
Upside: +3,257.58%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $0.75
Upside: +2,042.47%